Twenty-eight day Holter monitoring is poorly tolerated and insensitive for paroxysmal atrial fibrillation detection in cryptogenic stroke

Internal Medicine Journal

Volumn 44, Issue 5, 2014, Pages 505-508

  Tu, H T ^a   Spence, S ^a   Kalman, J M ^a   Davis, S M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Atrial fibrillation; Diagnosis; Holter monitoring; Screening; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HOLTER MONITOR; HOLTER MONITORING; HUMAN; IMAGING SOFTWARE; MALE; PRIORITY JOURNAL; SKIN IRRITATION; SUPRAVENTRICULAR PREMATURE BEAT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; ASYMPTOMATIC DISEASE; ATRIAL FIBRILLATION; ATRIAL PREMATURE COMPLEXES; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMORBIDITY; COMPLICATION; DIABETES MELLITUS; EPIDEMIOLOGY; FEASIBILITY STUDY; HYPERLIPIDEMIAS; LABORATORY DIAGNOSIS; MIDDLE AGED; PATIENT ATTITUDE; PILOT STUDY; PROSPECTIVE STUDY; PSYCHOLOGY; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY;

AGED; ASYMPTOMATIC DISEASES; ATRIAL FIBRILLATION; ATRIAL PREMATURE COMPLEXES; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS; ELECTROCARDIOGRAPHY, AMBULATORY; FALSE NEGATIVE REACTIONS; FEASIBILITY STUDIES; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS; PROSPECTIVE STUDIES; RECURRENCE; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84900010533     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12410     Document Type: Article

References (18)

1. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL etal. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
2. Schulz UG, Rothwell PM. Differences in vascular risk factors between etiological subtypes of ischemic stroke: importance of population-based studies. Stroke 2003; 34: 2050-2059.
3. Furie KL, Goldstein LB, Albers GW, Khatri P, Neyens R, Turakhia MP etal. Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012; 43: 3442-3453.
4. Seet RC, Friedman PA, Rabinstein AA. Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause. Circulation 2011; 124: 477-486.
5. Rabinstein AA, Fugate JE, Mandrekar J, Burns JD, Seet RC, Dupont SA etal. Paroxysmal atrial fibrillation in cryptogenic stroke: a case-control study. J Stroke Cerebrovasc Dis 2013; 22: 1405-1411.
6. Flint AC, Banki NM, Ren X, Rao VA, Go AS. Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Stroke and Monitoring for PAF in Real Time (SMART) Registry. Stroke 2012; 43: 2788-2790.
7. Cotter PE, Martin PJ, Ring L, Warburton EA, Belham M, Pugh PJ. Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke. Neurology 2013; 80: 1546-1550.
8. Ritter MA, Kochhauser S, Duning T, Reinke F, Pott C, Dechering DG etal. Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors. Stroke 2013; 44: 1449-1452.
9. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA etal. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-354.
10. Wallmann D, Tuller D, Wustmann K, Meier P, Isenegger J, Arnold M etal. Frequent atrial premature beats predict paroxysmal atrial fibrillation in stroke patients: an opportunity for a new diagnostic strategy. Stroke 2007; 38: 2292-2294.
11. Bhatt A, Majid A, Razak A, Kassab M, Hussain S, Safdar A. Predictors of occult paroxysmal atrial fibrillation in cryptogenic strokes detected by long-term noninvasive cardiac monitoring. Stroke Res Treat 2011; 2011: 172074.
12. Sposato LA, Klein FR, Jauregui A, Ferrua M, Klin P, Zamora R etal. Newly diagnosed atrial fibrillation after acute ischemic stroke and transient ischemic attack: importance of immediate and prolonged continuous cardiac monitoring. J Stroke Cerebrovasc Dis 2012; 21: 210-216.
13. Suissa L, Lachaud S, Mahagne MH. Optimal timing and duration of continuous electrocardiographic monitoring for detecting atrial fibrillation in stroke patients. J Stroke Cerebrovasc Dis 2013; 22: 991-995.
14. Rizos T, Guntner J, Jenetzky E, Marquardt L, Reichardt C, Becker R etal. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke 2012; 43: 2689-2694.
15. Tu HT, Campbell BC, Churilov L, Kalman JM, Lees KR, Lyden PD etal. Frequent early cardiac complications contribute to worse stroke outcome in atrial fibrillation. Cerebrovasc Dis 2011; 32: 454-460.
16. Kallmunzer B, Breuer L, Kahl N, Bobinger T, Raaz-Schrauder D, Huttner HB etal. Serious cardiac arrhythmias after stroke: incidence, time course, and predictors - a systematic, prospective analysis. Stroke 2012; 43: 2892-2897.
17. Sinha AM, Diener HC, Morillo CA, Sanna T, Bernstein RA, Di Lazzaro V etal. Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): design and rationale. Am Heart J 2010; 160: 36-41 e1.
18. Suissa L, Bresch S, Lachaud S, Mahagne MH. Brain natriuretic peptide: a relevant marker to rule out delayed atrial fibrillation in stroke patient. J Stroke Cerebrovasc Dis 2013; 22: e103-110.